Nanotherapeutics

Your Biopharmaceutical Development and Manufacturing Partner

Ohio Doctor Leads Cervical Cancer Study of Promising Drug

An Akron physician is leading a national clinical trial with the goal of improving survival rates for cervical cancer patients worldwide.

Dr. Charles Kunos, medical director of radiation oncology at Summa Akron City Hospital, is heading a National Cancer Institute study to determine whether a compound called Triapine results in a better chance for a cure when combined with the traditional treatments of chemotherapy and radiation.

Full Article

Copyright 2016 NANOTHERAPEUTICS, INC.  All rights reserved.